1.
|
Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: KTN32313R, NCT00477282
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068456, U10CA031946, CLB-30004, CALGB-30004, NCT00010218
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: Any age Sponsor: NCI, Other Protocol IDs: CDR0000269898, GOG-0186D, BIONUM-KTN22307, NCT00054119
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: KTN20405, NCT00062478
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NABTT-2006, JHOC-NABTT-2006, NCT00014521
|
|
6.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: KTN22208, NCT00097903
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 1 to 21 Sponsor: Other Protocol IDs: H-20159, KTN10010, BMP1350, NCT00586560
|